Trial Profile
Efficacy and Safety of Infliximab as First-line Therapy in Pediatric Crohn's Disease: a Randomized, Controlled, Open-label Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2023
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Azathioprine; Methylprednisolone
- Indications Crohn's disease
- Focus Therapeutic Use
- 03 May 2016 New trial record